Department of Medicine Grand Rounds

TOPIC: "CPC"
SPEAKERS: Peter Ott, MD, Marvin Slepian, MD, and Kawanjit Surapur, MD

Peter Ott, MD, is associate professor of clinical medicine at the University of Arizona College of Medicine - Tucson. A native of Germany, he received his medical degree from the University of Heidelberg and completed his medical residency training at the University of Arizona. He served one additional year as chief medical resident and then moved to Denver, Colo., where he completed fellowship training in cardiology at the University of Colorado. Dr. Ott returned to Germany for two years, working in cardiology/electrophysiology at a large tertiary referral center for cardiology in the southwest of Germany. He transferred to the University of Utah in Salt Lake City for additional training in cardiac electrophysiology before returning to the University of Arizona and his present position. He is the holder of The Peter Ott, MD Endowed Chair of Electrophysiology at the UA Sarver Heart Center.Dr. Ott is board certified in internal medicine, cardiovascular diseases and cardiac electrophysiology. His clinical expertise is the management of patients with cardiac arrhythmias, including catheter ablation therapy and device therapy (implantable defibrillator and pacemaker). Dr. Ott’s research interests are the electrophysiologic effects of heart failure, treatment of atrial fibrillation and treatment of cardiac arrhythmias with catheter ablation.

Marvin J. Slepian, MD, is Professor of Medicine, Professor and Associate Department Head of BioMedical Engineering and McGuire Scholar in the Eller College of Management, all at the University of Arizona. Dr. Slepian is the Director of the newly created Arizona Center for Accelerated Biomedical Innovation (ACABI) – a “creativity engine,” focused on novel solution development for unmet medical needs. Dr. Slepian attended Princeton (AB Biochemical Sciences and Science in Human Affairs ’77) and received his MD from the University of Cincinnati College of Medicine (’81 AOA).  He completed his residency in Internal Medicine at New York University–Bellevue Hospital in New York, where he served as Chief Resident in Medicine; clinical and research fellowships in Cardiology at Johns Hopkins University School of Medicine in Baltimore, Maryland; and clinical and research fellowships in Interventional Cardiology and a research fellowship in Artificial Organs at the Cleveland Clinic in Cleveland, Ohio.  In addition Dr Slepian also received post-doctoral training in Chemical Engineering and Polymer Chemistry at MIT. In parallel with his clinical career Dr. Slepian has had an extensive research career leading to the development of innovative diagnostics and therapeutics for cardiovascular diseases.  His work has focused on the development and use of novel biomaterials for tissue engineering, drug delivery and medical device development. His lab has developed many novel diagnostics and therapeutics which have found their way into clinical use today including: drug-eluting stent technologies, stent coatings, “polymer paving,” surgical anti-adhesive barriers, stretchable and biodegradable electronics, synthetic tissue sealants, myocardial revascularization and cell delivery methods and cardiovascular prosthetic devices - including the total artificial heart.  Dr. Slepian’s lab has also, for years, been heavily involved in basic science concentrating on three main areas: 1. the role of cell-matrix interactions in vascular disease, 2. basic aspects of cell-material interactions and 3. the impact of physical forces (notably shear and sound) on platelet activation. Dr Slepian is the author or coauthor of more than 250 articles, textbook chapters and abstracts, published in journals such as Science, Nature Materials, PNAS, PlosOne, Circulation, the New England Journal of Medicine, and Cardiovascular Pathology, and serves on several editorial review boards. He is a prolific inventor with more than 55 issued and filed patents and has been the founder of numerous medical device companies including FOCAL (NASDAQ), Endotex, Angiotrax, Hansen Medical (NASDAQ), Arsenal, 480 BioMedical, MC10 and SynCardia, and has been involved with bringing many new devices through the FDA regulatory process into clinical use, including most notably the total artificial heart.  He has received multiple awards for his academic and translational research activities including: the American Heart Association award for the most significant advance in cardiovascular medicine, election as fellow of the American Institute for Medical and Biological Engineering, is the current President of the International Society for Rotary Blood Pumps and was recently elected as fellow of the National Academy of Inventors. 

Kawanjit Surapur, MD was born in Canada and raised in the metro Detroit area. She went to Wayne State University for her undergraduate, Bachelor of Science in Biology, and worked in a nanoparticle laboratory with chlamydia-infected inflammatory murine models. Afterward, she went on to medical school at Wayne State University and completed residency training at the University of Arizona's Internal Medicine's program. Currently, she is applying to Sleep Medicine with future focus into Pulmonary Disease Medicine. Dr. Surapur serves mainly as the scheduling chief and academic chief while rotating at all residency sites. She will be helping compile an academic curriculum for the upcoming year. In her free time, she likes to run, play with her daughter, play videogames, and try new restaurants. 

Department of Medicine Grand Rounds

The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All Faculty, CME Planning Committee Members, and CME Office Reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.

Learning Objectives:

1. Diagnose a variety of internal medicine illnesses
2. Understand more clearly advances in therapy
3. Become truly professional physicians